521 related articles for article (PubMed ID: 9804426)
1. Structure of a glutamate-receptor ligand-binding core in complex with kainate.
Armstrong N; Sun Y; Chen GQ; Gouaux E
Nature; 1998 Oct; 395(6705):913-7. PubMed ID: 9804426
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the GluR0 ligand-binding core from Nostoc punctiforme in complex with L-glutamate: structural dissection of the ligand interaction and subunit interface.
Lee JH; Kang GB; Lim HH; Jin KS; Kim SH; Ree M; Park CS; Kim SJ; Eom SH
J Mol Biol; 2008 Feb; 376(2):308-16. PubMed ID: 18164033
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of ligand discrimination in the glutamate-binding pocket of the NMDA receptor.
Laube B; Schemm R; Betz H
Neuropharmacology; 2004 Dec; 47(7):994-1007. PubMed ID: 15555634
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms for ligand binding to GluR0 ion channels: crystal structures of the glutamate and serine complexes and a closed apo state.
Mayer ML; Olson R; Gouaux E
J Mol Biol; 2001 Aug; 311(4):815-36. PubMed ID: 11518533
[TBL] [Abstract][Full Text] [Related]
5. On the binding determinants of the glutamate agonist with the glutamate receptor ligand binding domain.
Speranskiy K; Kurnikova M
Biochemistry; 2005 Aug; 44(34):11508-17. PubMed ID: 16114887
[TBL] [Abstract][Full Text] [Related]
6. Stereostructure-activity studies on agonists at the AMPA and kainate subtypes of ionotropic glutamate receptors.
Johansen TN; Greenwood JR; Frydenvang K; Madsen U; Krogsgaard-Larsen P
Chirality; 2003 Feb; 15(2):167-79. PubMed ID: 12520509
[TBL] [Abstract][Full Text] [Related]
7. Crystal structures of the GluR5 and GluR6 ligand binding cores: molecular mechanisms underlying kainate receptor selectivity.
Mayer ML
Neuron; 2005 Feb; 45(4):539-52. PubMed ID: 15721240
[TBL] [Abstract][Full Text] [Related]
8. Model structures of the N-methyl-D-aspartate receptor subunit NR1 explain the molecular recognition of agonist and antagonist ligands.
Moretti L; Pentikäinen OT; Settimo L; Johnson MS
J Struct Biol; 2004 Mar; 145(3):205-15. PubMed ID: 14960371
[TBL] [Abstract][Full Text] [Related]
9. Emerging structural explanations of ionotropic glutamate receptor function.
McFeeters RL; Oswald RE
FASEB J; 2004 Mar; 18(3):428-38. PubMed ID: 15003989
[TBL] [Abstract][Full Text] [Related]
10. Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor.
Kunishima N; Shimada Y; Tsuji Y; Sato T; Yamamoto M; Kumasaka T; Nakanishi S; Jingami H; Morikawa K
Nature; 2000 Oct; 407(6807):971-7. PubMed ID: 11069170
[TBL] [Abstract][Full Text] [Related]
11. Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents.
Verleye M; André N; Heulard I; Gillardin JM
Brain Res; 2004 Jul; 1013(2):249-55. PubMed ID: 15193535
[TBL] [Abstract][Full Text] [Related]
12. The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
Clausen RP; Hansen KB; Calí P; Nielsen B; Greenwood JR; Begtrup M; Egebjerg J; Bräuner-Osborne H
Eur J Pharmacol; 2004 Sep; 499(1-2):35-44. PubMed ID: 15363949
[TBL] [Abstract][Full Text] [Related]
13. Tetrazolyl isoxazole amino acids as ionotropic glutamate receptor antagonists: synthesis, modelling and molecular pharmacology.
Frølund B; Greenwood JR; Holm MM; Egebjerg J; Madsen U; Nielsen B; Bräuner-Osborne H; Stensbøl TB; Krogsgaard-Larsen P
Bioorg Med Chem; 2005 Sep; 13(18):5391-8. PubMed ID: 16043357
[TBL] [Abstract][Full Text] [Related]
14. Lessons from more than 80 structures of the GluA2 ligand-binding domain in complex with agonists, antagonists and allosteric modulators.
Pøhlsgaard J; Frydenvang K; Madsen U; Kastrup JS
Neuropharmacology; 2011 Jan; 60(1):135-50. PubMed ID: 20713069
[TBL] [Abstract][Full Text] [Related]
15. Ligand-binding characteristics and related structural features of the expressed goldfish kainate receptors: identification of a conserved disulfide bond and three residues important for ligand binding.
Wo ZG; Oswald RE
Mol Pharmacol; 1996 Oct; 50(4):770-80. PubMed ID: 8863821
[TBL] [Abstract][Full Text] [Related]
16. Selective agonist binding of (S)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) and 2S-(2alpha,3beta,4beta)-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid (kainate) receptors: a molecular modeling study.
Pentikäinen OT; Settimo L; Keinänen K; Johnson MS
Biochem Pharmacol; 2003 Dec; 66(12):2413-25. PubMed ID: 14637199
[TBL] [Abstract][Full Text] [Related]
17. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
18. Tyr702 is an important determinant of agonist binding and domain closure of the ligand-binding core of GluR2.
Frandsen A; Pickering DS; Vestergaard B; Kasper C; Nielsen BB; Greenwood JR; Campiani G; Fattorusso C; Gajhede M; Schousboe A; Kastrup JS
Mol Pharmacol; 2005 Mar; 67(3):703-13. PubMed ID: 15591246
[TBL] [Abstract][Full Text] [Related]
19. Evolution of glutamate interactions during binding to a glutamate receptor.
Cheng Q; Du M; Ramanoudjame G; Jayaraman V
Nat Chem Biol; 2005 Nov; 1(6):329-32. PubMed ID: 16408071
[TBL] [Abstract][Full Text] [Related]
20. Binding site flexibility: molecular simulation of partial and full agonists within a glutamate receptor.
Arinaminpathy Y; Sansom MS; Biggin PC
Mol Pharmacol; 2006 Jan; 69(1):11-8. PubMed ID: 16219907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
